These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes]. Christiansen AL; Madsbad S Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000 [TBL] [Abstract][Full Text] [Related]
13. [Metformin and lactic acidosis--fact or fiction? A review of current data]. Bläuer SC; Keller U Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502 [No Abstract] [Full Text] [Related]
14. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us? Bosi E Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978 [TBL] [Abstract][Full Text] [Related]
16. Metformin. Stumvoll M; Häring HU; Matthaei S Endocr Res; 2007; 32(1-2):39-57. PubMed ID: 18271504 [No Abstract] [Full Text] [Related]
17. Mortality risk with sulphonylureas compared to metformin. Holden SE; Currie CJ Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964 [TBL] [Abstract][Full Text] [Related]
18. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment. Scheen AJ Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):383-94. PubMed ID: 22313172 [TBL] [Abstract][Full Text] [Related]
20. [Insulin sparing and metabolic control with metformin-insulin combination]. Isnard F Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986 [No Abstract] [Full Text] [Related] [Next] [New Search]